Company Filing History:
Years Active: 2007
Title: Sang-Ok Park: Innovator in Steroid Hormone Production
Introduction
Sang-Ok Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of steroid hormones. His innovative work has led to the development of methods and microorganisms that enhance the efficiency of hormone production.
Latest Patents
Sang-Ok Park holds two patents that focus on the conversion of sterols into steroid hormone precursors. The first patent describes a microorganism with the ability to convert sterol into androst-4-ene-3, 17-dione and androsta-1,4-diene-3, 17-dione. This microorganism, specifically a mutant strain of ATCC 29472, EUG-119, demonstrates an exceptional ability to convert sterols, making it highly valuable for mass production of steroid hormones. The second patent outlines a method for preparing androst-4-ene-3, 17-dione and androsta-1, 4-diene-3, 17-dione. This method involves heating sterols and emulsifiers, creating emulsified sterols, and adding them to the culture media of microorganisms, which results in a high yield of the desired compounds.
Career Highlights
Sang-Ok Park is currently associated with Eugene Science Inc., where he continues to advance his research in biotechnology. His work has garnered attention for its potential applications in the pharmaceutical industry, particularly in hormone therapy and related fields.
Collaborations
He has collaborated with notable colleagues, including Seung-Kwon Noh and Myung-Kuk Kim, to further enhance the research and development of innovative biotechnological solutions.
Conclusion
Sang-Ok Park's contributions to the field of steroid hormone production through his innovative patents and research at Eugene Science Inc. highlight his role as a key figure in biotechnology. His work not only advances scientific knowledge but also has practical implications for the pharmaceutical industry.